Company's Legal NameTenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.
Date of Inception 15 January 1986
Commercial Registeration Number 84008
Purpose of Company Producing, marketing, selling and storing pharmaceutical reagents for human and veterinary use. Producing, marketing, selling and storing diagnostic reagents necessary for individuals, laboratories and hospitals. Importing pharmaceutical reagents and raw materials necessary for serving the Company’s purposes without trading. Producing pharmaceutical reagents for human, veterinary, and diagnostic use for others and with others. Producing food supplements for human use for others and by others.
Law of Governance Law (43) of year 1974 and its executive regulations, as amended
CurrencyEGP
Fiscal Year January 1st to December 31st
Auditor's Name Ernst & Young
Headquarters Second Industrial Zone, plot number 5, Sixth of October, Egypt
SubsidiariesRameda for Pharmaceuticals Trading Company (SAE) - Ramecare Company (LLC) - Ramepharma Company (LLC)
Board of Directors Ayman Abbas - Shamel Aboul Fadl - Dr. Amr Morsy - Mahmoud Fayek - Dr. Mohamed Farouk - Tarek Abdel Rahman - Karim Zahran - Mohamed Gamal El Shoura - Hatem Soliman - Mirna Arif
Share Information
Corporate Information
Company's Legal NameTenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.
Date of Inception 15 January 1986
Commercial Registeration Number 84008
Purpose of Company Producing, marketing, selling and storing pharmaceutical reagents for human and veterinary use. Producing, marketing, selling and storing diagnostic reagents necessary for individuals, laboratories and hospitals. Importing pharmaceutical reagents and raw materials necessary for serving the Company’s purposes without trading. Producing pharmaceutical reagents for human, veterinary, and diagnostic use for others and with others. Producing food supplements for human use for others and by others.
Law of Governance Law (43) of year 1974 and its executive regulations, as amended
CurrencyEGP
Fiscal Year January 1st to December 31st
Auditor's Name Ernst & Young
Headquarters Second Industrial Zone, plot number 5, Sixth of October, Egypt
SubsidiariesRameda for Pharmaceuticals Trading Company (SAE) - Ramecare Company (LLC) - Ramepharma Company (LLC)
Board of Directors Ayman Abbas - Shamel Aboul Fadl - Dr. Amr Morsy - Mahmoud Fayek - Dr. Mohamed Farouk - Tarek Abdel Rahman - Karim Zahran - Mohamed Gamal El Shoura - Hatem Soliman - Mirna Arif
Investment Calculator